/
eHealth, Inc. and its subsidiaries, referred to throughout this report as eHealth, the Company, we, us or our, is a leading private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to expertly guide consumers through their health insurance enrollment and related options, whe…
$1.49
+$0.00 (+0.00%)
EOD Jul 17, 2026
12.00% operating margin is respectable but not wide. ROIC at 6.77%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 4.1%, steady but not accelerating.
Negative free cash flow of -$28M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$529M
▲ +4.1% YoY
Net Income (TTM)
$33M
▲ +298.2% YoY
Op. Margin
11.12%
▲ +7.6pp YoY
ROIC
6.43%
▲ +4.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$69M
▼ -34.9% YoY
Op. Cash Flow (TTM)
-$67M
▼ -38.0% YoY
Net Debt
$22M
Cash & Equiv.
$111M
5Y CAGR: -1.0%
Continue Research
eHealth (EHTH)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, eHealth scores 26/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
eHealth scores 26 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 11.1% operating margin and a 6.4% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh EHTH's valuation and scores 26/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.